They paid Pfizer a lot more per dose than other countries. There were also reports that they were willing to share data on outcomes more freely (or less bureauc

They paid Pfizer a lot more per dose than other countries. There were also reports that they were willing to share data on outcomes more freely (or less bureaucracy) than normal.